| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.24▼ | 5.04▲ | 5.07▲ | 5.05▲ | 5.38▼ |
| MA10 | 5.15▲ | 5.08▲ | 5.18▲ | 5.28▼ | 6.23▼ |
| MA20 | 5.07▲ | 5.19▲ | 5.17▲ | 5.42▼ | 5.91▼ |
| MA50 | 5.16▲ | 5.14▲ | 5.16▲ | 6.27▼ | 5.62▼ |
| MA100 | 5.19▲ | 5.27▼ | 5.40▼ | 5.95▼ | 6.77▼ |
| MA200 | 5.11▲ | 5.43▼ | 5.89▼ | 5.37▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.033▲ | -0.017▼ | -0.015▼ | -0.004▼ | -0.153▼ |
| RSI | 58.495▲ | 52.769▲ | 51.685▲ | 41.963▼ | 46.101▼ |
| STOCH | 86.881▲ | 26.907 | 21.771 | 26.613 | 19.700▼ |
| WILL %R | -29.687 | -57.516 | -57.516 | -58.633 | -78.088▼ |
| CCI | 77.649 | 24.711 | -28.298 | -41.539 | -98.443 |
|
Thursday, May 16, 2024 07:00 PM
Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent ... 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on ...
|
|
Thursday, May 16, 2024 08:00 AM
Acquisition further expands NEXGEL Health, Wellness, and Beauty consumer product portfolioSilly George is on a revenue run rate of approximately ...
|
|
Thursday, May 16, 2024 04:56 AM
AppTech Payments Corp. (Nasdaq: APCX), a pioneering Fintech company powering frictionless commerce, announces today the successful completion of the pilot program for its Banking-as-a-Service (BaaS) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 5.22 | 5.645 | 4.88 | 5.205 | 1,289,671 |
| 15/05/24 | 5.16 | 5.45 | 5.0851 | 5.23 | 129,472 |
| 14/05/24 | 5.07 | 5.28 | 4.945 | 5.00 | 80,678 |
| 13/05/24 | 4.96 | 5.15 | 4.915 | 4.95 | 260,248 |
| 10/05/24 | 5.22 | 5.24 | 4.63 | 4.85 | 150,312 |
| 09/05/24 | 5.24 | 5.30 | 5.09 | 5.18 | 241,170 |
| 08/05/24 | 5.61 | 5.69 | 5.17 | 5.26 | 137,485 |
| 07/05/24 | 6.02 | 6.02 | 5.66 | 5.68 | 189,931 |
| 06/05/24 | 5.72 | 5.91 | 5.565 | 5.76 | 54,036 |
| 03/05/24 | 5.82 | 5.85 | 5.645 | 5.65 | 80,628 |
|
|
||||
|
|
||||
|
|